2-Amino-N-(4-(5-(2-phenanthrenyl)-3-(trifluoromethyl)-1H-pyrazol-1-yl)phenyl)acetamide, also known as OSU-03012 or AR-12, is a PDK1 inhibitor that shows potential for anti-cancer therapy. Its uses include inducing cell death in various cancer cell lines and tumor xenografts, inhibiting tumor growth, and acting as a radiosensitizer and chemosensitizer. Studies have explored its use in glioblastoma, and a Phase 1 clinical trial investigated its use in adult patients with advanced solid tumors or lymphoma. The directory classifies it as a clinical API with a synthetic source/manufacturing origin. Other names for this substance include PDK1 inhibitor AR-12. Its PubChem CID is 10027278.
OSU-03012
| CAS No | 742112-33-0 |
|---|---|
| Molecular Formula | C26H19F3N4O |
| Molecular Weight | 460.4 g/mol |
| Synonyms | 2-amino-N-[4-[5-phenanthren-2-yl-3-(trifluoromethyl)pyrazol-1-yl]phenyl]acetamide |
Zoho Contact Form
"*" indicates required fields
Frequently Asked Questions
2-Amino-N-(4-(5-(2-phenanthrenyl)-3-(trifluoromethyl)-1H-pyrazol-1-yl)phenyl)acetamide, also known as OSU-03012 or AR-12, is a PDK1 inhibitor that shows potential for anti-cancer therapy.
The listed CAS number is 742112-33-0.
The listed molecular formula is C26H19F3N4O.
The listed molecular weight is 460.4 g/mol.
2-amino-N-[4-[5-phenanthren-2-yl-3-(trifluoromethyl)pyrazol-1-yl]phenyl]acetamide.
The source lists PDK1 inhibitor AR-12.